Stifel raised the firm’s price target on Alignment Healthcare to $14 from $12 and keeps a Buy rating on the shares. Alignment’s primary health plan with 86% of its members is now filtering as a 4 star+ plan on the CMS website after previously only filtering as a 3 star+ plan, notes the analyst, who adds that the stock is now trading back close to where it was prior to October 1, when the filters for 2025 became available.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Harris to propose Medicare to cover home care for more seniors, WSJ reports
- Alignment Healthcare enters agreement with Intermountain Health
- Humana, Alignment sold off on star rating confusion, says Barclays
- Humana falls after releasing 2025 Medicare Advantage offerings
- Health insurers unveil 2025 Medicare Advantage plans, Reuters reports